DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Repligen Corp (NASDAQ: RGEN)

32.09 -0.21 (-0.65%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RGEN $32.09 -0.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.04
Previous Close $32.30
Daily Range $31.68 - $32.40
52-Week Range $14.92 - $34.15
Market Cap $1.1B
P/E Ratio 129.20
Dividend (Yield) $0.00 (0.0%)
Volume 333,984
Average Daily Volume 476,342
Current FY EPS $0.31

Sector

Healthcare

Industry

Drug Makers

Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website: http://www.repligen.com/

News & Commentary

Is This Tiny Biotech Still a Buy at All-Time Highs?

Repligen may not be on your watchlist, but it has been (very) good to investors in recent years. Will the ride continue?

Perilous Reversal Watch: Repligen (RGEN)

Insider Trading Alert - RGEN, FGP And PSEM Traded By Insiders

A Tech Stocks Update for 2015

Repligen (RGEN) Enters Overbought Territory - Tale of the Tape

New Lifetime High Today: Repligen (RGEN)

The Hottest Opportunities in Tech Right Now

Repligen's (RGEN) CEO Walter Herlihy on Q4 2014 Results -- Earnings Call Transcript

Why Repligen Corporation Shares Manufactured a 13% Gain Today

Repligen Corporation shares rocketed higher. Here's what you need to know.

Friday's ETF Movers: PBE, PIN

See More RGEN News...

RGEN's Top Competitors

RGEN $32.09 (-0.65%)
Current stock: RGEN
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB